Jeffrey Wolf specializes in building new life-science companies from the ground up and has played an active role in supporting the growth of his companies. Mr. Wolf’s start-ups include gene-therapy company Avigen and EluSys Therapeutics, which is focused on the development of novel antibodies against infectious diseases. Mr. Wolf received his MBA. from Stanford Business School, JD from New York University School of Law, and his BA from the University of Chicago.
.svg)
